In this report, we describe two rare thyroid tumors with pathogenic FLCN alterations: one harboring a germline (heriditary) FLCN mutation in a patient with BHD syndrome and the other with a somatic (acquired) FLCN mutation. The gene discussed is FLCN; the disease is thyroid tumor.